Ligand · E15
E15 · (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-5,5-dimethyl-N-[(2R)-3-methylbutan-2-yl]-1,3-thiazolidine-4-carboxamide
E15, (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-5,5-dimethyl-N-[(2R)-3-methylbutan-2-yl]-1,3-thiazolidine-4-carboxamide (C35 H51 N5 O5 S, 653.9 g/mol), in…
- Component
- E15
- Formula
- C35 H51 N5 O5 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
E15 in 2 structures; the first of them:
- 3LIT · The crystal structure of htlv protease complexed with the inhibitor KNI-10681 · E15 A117 · binds ARG10, LEU30, ASP32, GLY34, ALA35, ASP36, MET37, VAL39 and 21 more
- 3LIT · The crystal structure of HTLV protease complexed with the inhibitor kni-10681 · E15 A117 · binds ARG10, LEU30, ASP32, GLY34, ALA35, ASP36, MET37, VAL39 and 21 more
Residues it binds most
LEU 2, ALA 2, ASP 2, GLY 2, VAL 2, ILE 2, MET 2, TRP 2, ARG 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.